Title,Authors,Date of Publication,Links
Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies,Simona ManniFrancesca Del BufaloConcetta Quintarelli,2023-06-09,"<a href=""https://www.nature.com/articles/s41467-023-38723-y"" target=""_blank"">https://www.nature.com/articles/s41467-023-38723-y</a>"
Universal redirection of CAR T cells against solid tumours via membrane-inserted ligands for the CAR,Angela Q. ZhangAlexander HostetlerDarrell J. Irvine,2023-06-08,"<a href=""https://www.nature.com/articles/s41551-023-01048-8"" target=""_blank"">https://www.nature.com/articles/s41551-023-01048-8</a>"
Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activity,Morgane BoulchMarine CazauxPhilippe Bousso,2023-05-29,"<a href=""https://www.nature.com/articles/s43018-023-00570-7"" target=""_blank"">https://www.nature.com/articles/s43018-023-00570-7</a>"
